Concepedia

Keith J. Watling

KJ

46

Publications

2.2K

Citations

26

H-Index

1977

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Addenbrooke's Hospital

Griffith University

Harvard University

University of Oxford

Keith J. Watling is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and neuroscience.

Top concepts

Publications per year

1977–2005

46

Publications

46

The purification and properties of <i>myo</i>-inositol monophosphatase from bovine brain

N S Gee, C I Ragan, Keith J. Watling et al. · Biochemical Journal · 1988 · 173 citations · Full text

, , +16

Novel 5-HT3 antagonists. Indole oxadiazoles

Christopher J. Swain, Robert J. Baker, Clare O. Kneen et al. · Journal of Medicinal Chemistry · 1991 · 166 citations · Full text

Dopaminergic Mechanisms in the Teleost Retina

Keith J. Watling, John E. Dowling · Journal of Neurochemistry · 1981 · 140 citations

Stimulation of angiogenesis by substance P and interleukin‐1 in the rat and its inhibition by NK<sub>1</sub>or interleukin‐1 receptor antagonists

Tai‐Ping D. Fan, De‐En Hu, Steven Guard et al. · British Journal of Pharmacology · 1993 · 134 citations · Full text

Dopamine receptors in the retina may all be linked to adenylate cyclase

Keith J. Watling, John E. Dowling, Leslie L. Iversen · Nature · 1979 · 124 citations

, , +9

Rows per page

1–5 of 46